menu ☰
menu ˟

Chronic Conditions Hub search

MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson’s Disease by Binding to AXIN1

Background/Aims: Parkinson’s disease (PD) is a frequently occurring condition that resulted from ...

lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma

was analysed by using qRT-PCR analysis and the data from The Cancer Genome Atlas. Cell growth and ...

Tanshinone IIA Inhibits High Glucose-Induced Collagen Synthesis via Nuclear Factor Erythroid 2-Related Factor 2 in Cardiac Fibroblasts

Results: The results indicate cardiac fibroblasts exposed to high glucose condition show increased cell ...

Hypoxia Preconditioning of Human MSCs: a Direct Evidence of HIF-1α and Collagen Type XV Correlation

hypoxic conditions, in particular for a short period, is beneficial for MSCs, as low O2 tension is similar ...

circZMYM2 Competed Endogenously with miR-335-5p to Regulate JMJD2C in Pancreatic Cancer

repressed the expression of its target miR-335-5p. MiR-335-5p attenuated pancreatic cancer development via ...

Development and evaluation of a WeChat-based life review programme for patients with cancer: protocol for a randomised controlled trial

internet-based life review programmes tailored to patients with cancer. This study aims to develop a WeChat-based ...

Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China

disease condition, as well as the low socioeconomic status of the patients. ...

Cardiac manifestations of McArdle disease

a satisfactory exercise tolerance and chronic troponin elevation. His brother and sister had mild HCM phenotypes. ...

TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis

Rheumatoid arthritis (RA) is associated with a high prevalence of atherosclerosis. Recently ...

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

arthritis (PsA) over 2 years in the FUTURE 2 study (NCT01752634). This post hoc analysis assessed the ...

IPH Logo

Filter by content type:

Filter by journal